Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses
Hye Jung Park, Jung‐Won Park, Sae‐Hoon Kim, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 10, pp. 1349-1356
Closed Access | Times Cited: 25

Showing 25 citing articles:

Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 2, pp. 289-300.e4
Open Access | Times Cited: 40
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
Chiraphat Kloypan, Napatrupron Koomdee, Patompong Satapornpong, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1077-1077
Open Access | Times Cited: 49
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
Therdpong Tempark, Shobana John, Pawinee Rerknimitr, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
Mu-Tzu Chu, Wan‐Chun Chang, Shih-Cheng Pao, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 177-177
Open Access | Times Cited: 20
Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
Chun‐Bing Chen, Wei‐Kai Hung, Chuang‐Wei Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
Patompong Satapornpong, Jirawat Pratoomwun, Pawinee Rerknimitr, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 38
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
Renato de Filippis, John M. Kane, Nazar Kuzo, et al.
European Neuropsychopharmacology (2022) Vol. 60, pp. 25-37
Open Access | Times Cited: 24
A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions
Abdelbaset Elzagallaai, Awatif M. Abuzgaia, Michael Rieder
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs
Hana Krismawati, Maria Harianja, Antonius Oktavian, et al.
The Lancet Regional Health - Southeast Asia (2025) Vol. 34, pp. 100555-100555
Open Access
Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity
Haiqin Jiang, Chuang‐Wei Wang, Zhaoxi Wang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 18
GenotypingHLAalleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
Thawinee Jantararoungtong, Therdpong Tempark, Napatrupron Koomdee, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1049-1064
Open Access | Times Cited: 21
Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
Jirawat Pratoomwun, Paul Thomson, Kanoot Jaruthamsophon, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
Advances in the pathogenic, genetic and immunological studies of leprosy
Zihao Mi, Hong Liu, Furen Zhang
hLife (2023) Vol. 2, Iss. 1, pp. 6-17
Open Access | Times Cited: 7
Genetics of Severe Cutaneous Adverse Reactions
Shang-Chen Yang, Chun‐Bing Chen, Mao‐Ying Lin, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides
Mubarak Almutairi, Adam Lister, Qing Zhao, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 8, pp. 1031-1042
Open Access | Times Cited: 5
Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
Chih-Hsuan Wung, Chuang‐Wei Wang, Kuo‐Chu Lai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Dual approaches in pharmacogenetics: Developing PCR-SSP and RT-PCR methods for HLA-B*13:01 screening to prevent dapsone and Co-trimoxazole SCARs
Jirapat Attapong, Chollanot Kaset, Nontaya Nakkam, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34977-e34977
Open Access | Times Cited: 1
Association of HLA-B∗13:01 with DRESS and HLA-A∗31:01 with eosinophilia in SJS/TEN induced by carbamazepine
Hyun Kim, Ji-Su Shim, Ga-Yoon Park, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3436-3438.e3
Closed Access | Times Cited: 1
Advances in the Diagnosis of Leprosy
Mukul Sharma, Pushpendra Singh
Frontiers in Tropical Diseases (2022) Vol. 3
Open Access | Times Cited: 5
Dapsone hypersensitivity syndrome
Qing Zhao, Lele Sun, Yonghu Sun, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 2
Genetic markers of drug hypersensitivity in pediatrics: current state and promise
Abdelbaset Elzagallaai, Michael Rieder
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 6, pp. 715-728
Closed Access | Times Cited: 4
Leprosy Update in China, 2019
Le Wang, Peiwen Sun, Meiwen Yu, et al.
International Journal of Dermatology and Venereology (2021) Vol. 5, Iss. 1, pp. 15-19
Open Access | Times Cited: 2
Overview and Current Advances in Dapsone Hypersensitivity Syndrome
Zhen‐Zhen Wang, Rui Zeng, Ziwei Wu, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 11, pp. 635-645
Closed Access
Dapsone

Reactions Weekly (2020) Vol. 1821, Iss. 1, pp. 91-91
Closed Access
Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
Hui Jong Yeom, Hyun Hwa Kim, Hyun Jee Kim, et al.
Journal of Pharmacoepidemiology and Risk Management (2021) Vol. 13, Iss. 2, pp. 70-77
Open Access
Page 1

Scroll to top